Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Neogenomics Inc NEO

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical... see more

Recent & Breaking News (NDAQ:NEO)

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors

Business Wire December 9, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 6, 2023 in NeoGenomics Lawsuit - NEO

Newsfile December 9, 2022

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 9, 2022

NEOGENOMICS, INC. (NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. (NEO)

Newsfile December 9, 2022

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm

Accesswire December 9, 2022

NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023

PR Newswire December 9, 2022

NEOGENOMICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO

Business Wire December 8, 2022

ROSEN, A LEADING LAW FIRM, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NEO

PR Newswire December 8, 2022

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors

Business Wire December 8, 2022

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 8, 2022

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm

PR Newswire December 8, 2022

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against NeoGenomics, Inc. (NEO)

Business Wire December 7, 2022

EQUITY ALERT: Rosen Law Firm Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NEO

Business Wire December 7, 2022

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors

Business Wire December 7, 2022

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors

Business Wire December 7, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 6, 2023 in NeoGenomics Lawsuit - NEO

Newsfile December 7, 2022

INVESTOR ALERT: NeoGenomics, Inc. Investors with Substantial Losses Have Opportunity to Lead the NeoGenomics Class Action Lawsuit - NEO

Business Wire December 7, 2022

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 7, 2022

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm

Business Wire December 7, 2022

INVESTOR ACTION DEADLINE: The Schall Law Firm Files Class Action on Behalf of Investors in NeoGenomics, Inc. and Advises Shareholders with Losses of $500,000 to Contact the Firm

Accesswire December 6, 2022